PLIANT THERAPEUTICS, INC. Debt Securities, Available-for-sale, Unrealized Gain
PLIANT THERAPEUTICS, INC. (PLRX) reported Debt Securities, Available-for-sale, Unrealized Gain of $1.00 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedGain · last filed 2022-11-08
- PLIANT THERAPEUTICS, INC. debt securities, available-for-sale, unrealized gain for the quarter ending 2022-09-30 was $1.00K.
- PLIANT THERAPEUTICS, INC. debt securities, available-for-sale, unrealized gain for the quarter ending 2022-06-30 was $0.00.
- PLIANT THERAPEUTICS, INC. debt securities, available-for-sale, unrealized gain for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- PLIANT THERAPEUTICS, INC. debt securities, available-for-sale, unrealized gain for the quarter ending 2021-12-31 was -$7.00K, a 275.00% decline year-over-year.
- PLIANT THERAPEUTICS, INC. debt securities, available-for-sale, unrealized gain for fiscal 2020 was $15.00K, a 1400.00% increase from fiscal 2019.
- PLIANT THERAPEUTICS, INC. debt securities, available-for-sale, unrealized gain for fiscal 2019 was $1.00K.
| Period end | Debt Securities, Available-for-sale, Unrealized Gain 3 month | Debt Securities, Available-for-sale, Unrealized Gain 6 month | Debt Securities, Available-for-sale, Unrealized Gain 9 month | Debt Securities, Available-for-sale, Unrealized Gain 12 month |
|---|---|---|---|---|
| 2022-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $1.00K derived: sum of 2 quarters · filed 2022-11-08 | $1.00K 10-Q · filed 2022-11-08 | -$6.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $0.00 10-Q · filed 2022-08-08 | -$7.00K derived: sum of 3 quarters · filed 2022-11-08 | -$16.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-09 | -$7.00K derived: sum of 2 quarters · filed 2022-11-08 | -$16.00K derived: sum of 3 quarters · filed 2022-11-08 | -$19.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-12-31 | -$7.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2022-11-08 | -$16.00K derived: sum of 2 quarters · filed 2022-11-08 | -$19.00K derived: sum of 3 quarters · filed 2022-11-08 | $1.00K 10-Q · filed 2022-11-08 |
| 2021-09-30 | -$9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$12.00K derived: sum of 2 quarters · filed 2021-11-09 | $8.00K 10-Q · filed 2021-11-09 | $12.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2021-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $17.00K 10-Q · filed 2021-08-09 | $21.00K derived: sum of 3 quarters · filed 2022-03-01 | $26.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2021-03-31 | $20.00K 10-Q · filed 2021-05-10 | $24.00K derived: sum of 2 quarters · filed 2022-03-01 | $29.00K derived: sum of 3 quarters · filed 2022-03-01 | |
| 2020-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $9.00K derived: sum of 2 quarters · filed 2022-03-01 | $15.00K 10-K · filed 2022-03-01 | |
| 2020-09-30 | $5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $11.00K 10-Q · filed 2020-11-10 | ||
| 2020-06-30 | $6.00K 10-Q · filed 2020-08-11 | |||
| 2019-12-31 | $1.00K 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |